A woman thinks her routine blood tests are behind her when she receives an explanation of benefits showing zero patient ...

I've been covering Quest Diagnostics for some time. While it can be argued that the company has beaten estimates, it's also clear that positive catalysts are few. I've been neutral going on for a year ...

Quest Diagnostics reaffirmed as a buy: organic growth, macro demand, strong margins, investment-grade ratings, and dividend ...

Jan Burnett thinks her routine blood tests are behind her when she receives an explanation of benefits showing zero patient ...